Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice

Arthritis and Rheumatism

Volumn 50, Issue 9, 2004, Pages 3023-3034

  Gregory, Julia L ^a   Leech, Michelle T ^a   David, John R ^b   Yang, Yuan H ^a   Dacumos, April ^a   Hickey, Michael J ^a  

^a MONASH UNIVERSITY   (Australia)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; MACROPHAGE MIGRATION INHIBITION FACTOR; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CREMASTER MUSCLE; ENDOTHELIUM CELL; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LEUKOCYTE ROLLING; MACROPHAGE MIGRATION INHIBITION; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNOVIUM; VENULE; WILD TYPE;

ANIMALS; CELL COMMUNICATION; ENDOTHELIAL CELLS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICROCIRCULATION; MICROSCOPY; MODELS, ANIMAL; MUSCLE, SKELETAL; P-SELECTIN; SYNOVIAL MEMBRANE;

EID: 4444297560     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20470     Document Type: Article

References (46)

1. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80-2.
2. David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interactions. Proc Natl Acad Sci U S A 1966;56:72-7.
3. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997;3:320-4.
4. Onodera S, Suzuki K, Matsuno T, Kaneda K, Takagi M, Nishihira J. Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 1997;92:131-7.
5. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994;179:1895-902.
6. Liew FY. Regulation of nitric oxide synthesis in infectious and autoimmune diseases. Immunol Lett 1994;43:95-8.
7. Onodera S, Tanji H, Suzuki K, Kaneda K, Mizue Y, Sagawa A, et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatism joints. Cytokine 1998;11:163-7.
8. Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999;42:1601-8.
9. Morand EF, Leech M, Weedon H, Metz C, Bucala R, Smith MD. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology (Oxford) 2002;41:558-62.
10. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756-9.
11. Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996;183:277-82.
12. Mikulowska A, Metz CN, Bucala R, Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997;158:5514-7.
13. Leech M, Metz C, Santos L, Peng T, Holdsworth SR, Bucala R, et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 1998;41:910-7.
14. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999;189:341-6.
15. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hulther L, et al. Protection from septic shock by neutralization of macrophage inhibitory factor. Nat Med 2000;6:164-70.
16. Santos L, Hall C, Metz CN, Bucala R, Morand EF. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interactions with glucocorticoids. Clin Exp Immunol 2001;123:309-14.
17. Denkinger CM, Denkinger M, Kort JJ, Metz C, Forsthuber TG. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J Immunol 2003;170:1274-82.
18. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
19. Roger T, David JR, Glauser MP, Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001;414:920-4.
20. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A 2002;99:345-50.
21. Granger N, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994;55:662-75.
22. Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 1999;79:181-213.
23. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14.
24. Makita H, Nishimura M, Miyamoto K, Nakano T, Tanino Y, Hirokawa J, et al. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med 1998;158:573-9.
25. Kanwar S, Bullard DC, Hickey MJ, Smith CW, Beaudet AL, Wolitzky BA, et al. The association between α4-integrin, P-selectin, and E-selectin in an allergic model of inflammation. J Exp Med 1997;185:1077-87.
26. Hickey MJ, Issekutz AC, Reinhardt PH, Fedorak RN, Kubes P. Endogenous interleukin-10 regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia. Circ Res 1998;83:1124-31.
27. Yang YH, Hutchinson P, Leech M, Holdsworth SR, Morand EF. Anti-inflammatory effect of lipocortin-1 in experimental arthritis. Inflammation 1997;21:583-96.
28. 4 integrin. J Immunol 1999;163:3441-8.
29. Norman MU, Van De Velde N, Timoshanko JR, Issekutz A, Hickey MJ. Overlapping roles of endothelial selectins and VCAM-1 in immune complex-induced leukocyte recruitment in the cremasteric microvasculature. Am J Pathol 2003;163:1491-503.
30. Kubes P, Kanwar S. Histamine induces leukocyte rolling in post-capillary venules: a P-selectin-mediated event. J Immunol 1994;152:3570-7.
31. Veihelmann A, Szczesny G, Nolle D, Krombach F, Refior HJ, Messmer K. A novel model for the study of synovial microcirculation in the mouse knee joint in vivo. Res Exp Med (Berl) 1998;198:43-54.
32. lpr (lupus-prone) mice: roles of P- and E-selectin. J Immunol 2002;168:4728-36.
33. Drummond AE, Dyson M, Thean E, Groome NP, Robertson DM, Findlay JK. Temporal and hormonal regulation of inhibin protein and subunit mRNA expression by post-natal and immature rat ovaries. J Endocrinol 2000;166:339-54.
34. Huang XR, Holdsworth SR, Tipping PG. Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 1994;46:69-78.
35. Yipp BG, Andonegui G, Howlett CJ, Robbins SM, Hartung T, Ho M, et al. Profound differences in leukocyte-endothelial cell responses to lipopolysaccharide versus lipoteichoic acid. J Immunol 2002;168:4650-8.
36. McCafferty DM, Kanwar S, Granger DN, Kubes P. E/P-selectin-deficient mice: an optimal mutation for abrogating antigen but not tumor necrosis factor-α-induced immune responses. Eur J Immunol 2000;30:2362-71.
37. Weller A, Isenmann S, Vestweber D. Cloning of the mouse endothelial selectins: expression of both E- and P-selectin is inducible by tumor necrosis factor-α. J Biol Chem 1992;267:15176-83.
38. De Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Fauboin WA, et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001;2:1061-6.
39. Leech M, Lacey D, Xue JR, Santos L, Hutchinson P, Wolvetang E, et al. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 2003;48:1881-9.
40. Perry MA, Granger DN. Role of CD11/CD18 in shear-rate dependent leukocyte-endothelial cell interactions in cat mesenteric venules. J Clin Invest 1991;87:1798-804.
41. Huang XR, Chun Hui CW, Chen YX, Wong BC, Fung PC, Metz C, et al. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology 2001;121:619-30.
42. Lan HY, Bacher M, Yang N, Mu X, Mikolic-Paterson DJ, Metz C, et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 1997;185:1455-65.
43. Stavitsky AB, Xianli J. In vitro and in vivo regulation by macrophage migration inhibitory factor (MIF) of expression of MHC-II, costimulatory, adhesion, receptor, and cytokine molecules. Cell Immunol 2002;217:95-104.
44. Lin SG, Yu XY, Chen YX, Huang XR, Metz C, Bucala R, et al. De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res 2000;87:1202-8.
45. Davenpeck KL, Zagorski J, Schleimer RP, Bochner BS. Lipopolysaccharide- induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: regulation by glucocorticoids and role of cytokines. J Immunol 1998;161:6861-70.
46. Suzuki H, Schmid-Schonbein GW, Suematsu M, Delano FA, Forrest MJ, Miyasaka M, et al. Impaired leukocyte-endothelial cell interaction in spontaneously hypertensive rats. Hypertension 1994;24:719-27.